Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation.

Kim JI, Young GD, Jin L, Somlyo AV, Eto M.

Histochem Cell Biol. 2009 Aug;132(2):191-8. doi: 10.1007/s00418-009-0604-2. Epub 2009 May 13.


Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.

Kim JI, Urban M, Young GD, Eto M.

Am J Physiol Cell Physiol. 2012 Jul 1;303(1):C58-68. doi: 10.1152/ajpcell.00118.2012. Epub 2012 Apr 25.


CPI-17-deficient smooth muscle of chicken.

Kitazawa T, Polzin AN, Eto M.

J Physiol. 2004 Jun 1;557(Pt 2):515-28. Epub 2004 Apr 16.


Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase.

Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP.

Biochem J. 2002 Oct 15;367(Pt 2):517-24.


Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle.

Patel CA, Rattan S.

Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G830-7. Epub 2006 Jun 8.


Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells.

Eto M, Kirkbride JA, Chugh R, Karikari NK, Kim JI.

Biochem Biophys Res Commun. 2013 Apr 26;434(1):137-42. doi: 10.1016/j.bbrc.2013.03.055. Epub 2013 Mar 26.


Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders.

Ohama T, Hori M, Momotani E, Iwakura Y, Guo F, Kishi H, Kobayashi S, Ozaki H.

Am J Physiol Gastrointest Liver Physiol. 2007 May;292(5):G1429-38. Epub 2007 Feb 15.


Tonic and phasic smooth muscle contraction is not regulated by the PKCĪ± - CPI-17 pathway in swine stomach antrum and fundus.

Zhang Y, Hermanson ME, Eddinger TJ.

PLoS One. 2013 Sep 18;8(9):e74608. doi: 10.1371/journal.pone.0074608. eCollection 2013.


Cell culture retains contractile phenotype but epigenetically modulates cell-signaling proteins of excitation-contraction coupling in colon smooth muscle cells.

Shi XZ, Sarna SK.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G337-45. doi: 10.1152/ajpgi.00369.2012. Epub 2012 Dec 13.


Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients.

Ohama T, Hori M, Fujisawa M, Kiyosue M, Hashimoto M, Ikenoue Y, Jinno Y, Miwa H, Matsumoto T, Murata T, Ozaki H.

J Gastroenterol. 2008;43(11):858-65. doi: 10.1007/s00535-008-2241-2. Epub 2008 Nov 18.


Embryonic development of the ureter and bladder: acquisition of smooth muscle.

Baker LA, Gomez RA.

J Urol. 1998 Aug;160(2):545-50.


Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin.

Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA.

Dev Biol. 1992 Oct;153(2):185-93.


Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle.

Hypolite JA, Chang S, LaBelle E, Babu GJ, Periasamy M, Wein AJ, Chacko S.

Am J Physiol Renal Physiol. 2009 Mar;296(3):F658-65. doi: 10.1152/ajprenal.90221.2008. Epub 2008 Dec 3.


Urothelial sonic hedgehog signaling plays an important role in bladder smooth muscle formation.

Shiroyanagi Y, Liu B, Cao M, Agras K, Li J, Hsieh MH, Willingham EJ, Baskin LS.

Differentiation. 2007 Dec;75(10):968-77. Epub 2007 May 9.


Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.

Qi F, Ogawa K, Tokinaga Y, Uematsu N, Minonishi T, Hatano Y.

Anesth Analg. 2009 Aug;109(2):412-7. doi: 10.1213/ane.0b013e3181ac6d96.


Role of Rho kinase in endothelin-1-induced phosphorylation of CPI-17 in rat bronchial smooth muscle.

Sakai H, Chiba Y, Misawa M.

Pulm Pharmacol Ther. 2007;20(6):734-9. Epub 2006 Sep 22.


Smooth muscle-selective CPI-17 expression increases vascular smooth muscle contraction and blood pressure.

Su W, Xie Z, Liu S, Calderon LE, Guo Z, Gong MC.

Am J Physiol Heart Circ Physiol. 2013 Jul 1;305(1):H104-13. doi: 10.1152/ajpheart.00597.2012. Epub 2013 Apr 19.


Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle.

Ohama T, Hori M, Sato K, Ozaki H, Karaki H.

J Biol Chem. 2003 Dec 5;278(49):48794-804. Epub 2003 Sep 25.

Supplemental Content

Support Center